Algert Global LLC Guardant Health, Inc. Transaction History

Algert Global LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$16.07 - $31.84 $273,190 - $541,280	17,000 Added 23.22%	90,220 $2.61 Million
Q1 2024 May 14, 2024	SELL	$17.13 - $26.91 $10,757 - $16,899	-628 Reduced 0.85%	73,220 $1.51 Million
Q4 2023 Feb 14, 2024	BUY	$21.58 - $29.5 $1.14 Million - $1.55 Million	52,608 Added 247.68%	73,848 $2 Million
Q3 2023 Nov 13, 2023	SELL	$25.8 - $39.97 $705,372 - $1.09 Million	-27,340 Reduced 56.28%	21,240 $630,000
Q2 2023 Aug 14, 2023	BUY	$20.94 - $38.01 $1.02 Million - $1.85 Million	48,580 New	48,580 $1.74 Million
Q1 2022 May 16, 2022	SELL	$48.25 - $100.49 $215,098 - $447,984	-4,458 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$98.77 - $132.17 $440,316 - $589,213	4,458 New	4,458 $557,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.